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24. Standard curves for blood Interferon concentration were
generated for given doses. Interferon levels were measured
daily for 7 days in all patients using ELISA assay speciﬁc to
used Interferon molecule.
Results: All samples were reactive with ELISA assay.
Concentration and assay results correlated in a linearly
manner. Standard curve was generated for each run of
samples for all patients. Interferon level has been traced
from 1st to 7th day.
There was signiﬁcant inter-patient variation in levels
of detectable interferon for both responders and non-
responders. In all 7 cases with sustained viral response,
interferon levels were low or undetectable in days 6 and
7. Even one patient whose interferon level was traced in
the 4th day was also a responder. There is no signiﬁcant
difference between responders and non-responders either
in daily median concentration through-out the 7 days, nor
in the association of viral load or genotype to interferon
concentration with viral clearance.
Conclusion: Tracing of single dose Reiferon Retard®
demonstrated detectable interferon levels up to 7 days.
Although interferon levels were low or undetectable in 7
out of 14 cases at days 6 and 7, sustained viral response
was achieved in all cases. Suggested explanation: interferon
attaches to cell receptors by PEG molecule and acts on
cellular level till next dose is received. There might be
other host factors predicting interferon response other than
pharmacokinetics of PEG interferon.
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Background: Despite the fact that hepatitis C virus (HCV)
is a common infection in China, there is little information
on prevalence rates, particularly in the rural area of Jilin
province. Blood transfusions and more intravenous drug used
are risk factors of spreading the virus. In order to investigate
HCV infection status and related factors associated with HCV
infections among rural people in Jilin province, a cross-
sectional population-based survey was conducted.
Methods: Blood samples from 2,849 subjects were analyzed
for Anti-HCV, hematological, blood chemistry and HCV-RNA
tests. A standardized questionnaire concerning the socio-
demographic characteristics and potential risk factors was
carried out.
Results: The HCV infection was detected in 33.2%
(947/2849) of subjects at this survey. HCV RNA were
detected in 873 HCV-infected individuals, 18.8% (164) of
HCV-infected individuals has a spontaneous clearance of
virus infection. 57.7% (409/709) of HCV-infected individuals
were detected to have high-levels of the viral load (>400000
IU/ml). HCV genotypes of 252 samples were examined,
142 (56.3%) individuals had the infection of subtype 1b;
101 (40.1%) had subtype 2a; 9 (3.6%) had a co-infection
of subtype 1b/2a. Multivariate analyses revealed that risk
factors related to HCV infection were unsafe injections (OR:
11.7; 95%CI: 5.6 24.2), caffeine-sodium benzoate injections
(OR: 7.1; 95%CI: 4.4 11.3), age (40years, OR: 5.8; 95%CI:
3.9 8.1) and sex (in male, OR: 1.8; 95%CI: 1.5 2.2).
Conclusion: The most common source of HCV spreading
was a caffeine-sodium benzoate injection. Subtype 1b and
2a are predominant HCV genotypes in the area of Jilin
province. Public health measures should be taken to reduce
the abuse of intravenous injections and exposure of unsafe
injections.
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Background: Hepatitis C virus (HCV) heterogeneity accounts
for the lack of successful anti-viral therapy in some patients.
The object of this study is to determine HCV genotype and
subtype distribution in China mainland.
Methods: A total of 788 HCV RNA positive serum samples
were collected from chronic HCV infected patients from
14 geographic areas in China during 2009.10 2011.4.
Nucleotide sequence analysis of the NS5B and/or CORE-
E1 regions of the HCV genome was performed on samples.
Phylogenetic analysis was used for analysis of HCV genotype
and subtype.
Result: HCV genotype was determined in 747 samples
[94.80% (747/788)]. Genotype 1, 2, 3 and 6 were detected,
at frequencies of 73.49%, 18.88%, 4.95% and 2.68%,
respectively. No genotype 4 and 5 strains were found.
We detected subtypes 1b, 2a, 3a, 6a, 3b, 6n, and 1a
at frequencies of 73.09%, 18.88%, 3.21%, 2.14%, 1.74%,
0.54%, and 0.40%, respectively. Subtype 1b was the most
predominant [73.09% (546/747)] followed by 2a [18.88%
(141/747)].
Conclusion: This study demonstrated a genetic
heterogeneity of HCV infection in China, with at least
four HCV genotypes and seven subtypes. Clinical trials
of direct anti-HCV agents should consider this genetic
heterogeneity.
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HCV NS5A is a remarkable protein as it clearly plays multiple
roles in mediating viral replication, host-cell interactions,
and viral pathogenesis. But on the impact of cell growth,
there were different study results. NS5ATP9, also known as
p15PAF, L5, OEACT-1, and KIAA0101, was ﬁrst identiﬁed as
a proliferating cell nuclear antigen-binding protein. Earlier
studies have shown that it might play an important role
in HCV infection. In the present study, we showed that
overexpression of NS5ATP9 inhibited the proliferation of HCC
cells, whereas knockdown of NS5ATP9 by interfering RNA
(RNAi) promoted the growth of HCC cells. Under conditions
of NS5A overexpression, RNAi targeting of NS5ATP9 could
reverse the inhibition of HCC cell proliferation by NS5A,
suggesting that NS5ATP9 could be an anti-oncogene that
plays an important role in the suppression of cell growth
mediated by HCV NS5A via MEK/ERK signal pathway.
These ﬁndings may provide new insight into the NS5A and
NS5ATP9.
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Background: Hepatitis C virus (HCV) infection is a common
cause of chronic hepatitis and is currently treated with
